Login / Signup

Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial.

Omar Abdel-RahmanP A TangW Y Cheung
Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
There is considerable heterogeneity in risk factors among patients with different subtypes of breast cancer. In particular, factors associated with high estrogen levels seem to be associated with luminal breast cancer rather than other breast cancer subtypes.
Keyphrases
  • risk factors
  • clinical trial
  • breast cancer risk
  • estrogen receptor
  • phase ii